Real-World Analysis Supports More Frequent Anti-VEGF Dosing for First-Year nAMD
July 21st 2018Researchers found that, contrary to popular opinion, about 80% of patients are receiving at least 7 dosing regimens of anti-VEGF in their first year of treatment, and that frequency has been proven to improve visual acuity.